Switching to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Stribild®): effects on T-cell compartment and HIV reservoirs

被引：0
|
作者：
Merlini, Esther [1 ]
Cazzaniga, Federico [1 ]
Casabianca, Anna [2 ]
Orlandi, Chiara [2 ]
Ancona, Giuseppe [1 ]
Cogliandro, Viola [1 ]
Tincati, Camilla [1 ]
Bini, Teresa [1 ]
Magnani, Mauro [2 ]
Monforte, Antonella d'Arminio [1 ]
Marchetti, Giulia [1 ]
机构：
[1] Univ Milan, Hlth Sci, Milan, Italy
[2] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P100
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (Stribild®): A Review of Its Use in the Management of HIV-1 Infection in Adults
    Caroline M. Perry
    [J]. Drugs, 2014, 74 : 75 - 97
  • [2] Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (Stribild®): A Review of Its Use in the Management of HIV-1 Infection in Adults
    Perry, Caroline M.
    [J]. DRUGS, 2014, 74 (01) : 75 - 97
  • [3] Single-tablet regimen with elvitegravir, cobicistat, emtricitabine and tenofovir for the treatment of early HIV infection
    Teira, Ramon
    Galindo, Maria
    Montero, Marta
    Portilla, Raquel
    Ferrer, Ana
    Martinez, Elisa
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [4] Stribild® (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate): A New Paradigm for HIV-1 Treatment
    Manzardo, Christian
    Gatell, Jose M.
    [J]. AIDS REVIEWS, 2014, 16 (01) : 35 - 42
  • [5] Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet for HIV-1 Infection Treatment
    Olin, Jacqueline L.
    Spooner, Linda M.
    Klibanov, Olga M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (12) : 1671 - 1677
  • [6] Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen
    Mathias, Anita A.
    Hinkle, John
    Menning, Mark
    Hui, James
    Kaul, Sanjeev
    Kearney, Brian P.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 (02) : 167 - 173
  • [7] Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection
    Cohen, Calvin
    Elion, Richard
    Ruane, Peter
    Shamblaw, David
    DeJesus, Edwin
    Rashbaum, Bruce
    Chuck, Steven L.
    Yale, Kitty
    Liu, Hui C.
    Warren, David R.
    Ramanathan, Srinivasan
    Kearney, Brian P.
    [J]. AIDS, 2011, 25 (06) : F7 - F12
  • [8] Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure
    Inciarte, A.
    Leal, L.
    Gonzalez, E.
    Leon, A.
    Lucero, C.
    Mallolas, J.
    Torres, B.
    Laguno, M.
    Rojas, J.
    Martinez-Rebollar, M.
    Gonzalez-Cordon, A.
    Cruceta, A.
    Arnaiz, J. A.
    Gatell, J. M.
    Garcia, F.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (10) : 2857 - 2861
  • [9] Single-tablet regimen of emtricitabine/tenofovir disoproxil fumarate plus cobicistat-boosted elvitegravir increase adherence for HIV postexposure prophylaxis in sexual assault victims
    Malinverni, Stefano
    Bedoret, Floriane
    Bartiaux, Magali
    Gilles, Christine
    De Wit, Stephane
    Libois, Agnes
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2021, 97 (05) : 329 - 333
  • [10] Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen: A Review of Its Use in HIV Infection
    Deeks, Emma D.
    [J]. DRUGS, 2014, 74 (17) : 2079 - 2095
12345